ABBV vs. FUL
ABBV (AbbVie Inc.) and FUL (H.B. Fuller Company) are both stocks. ABBV operates in Drug Manufacturers - General (Healthcare), while FUL operates in Specialty Chemicals (Basic Materials). Over the past 10 years, ABBV returned 18.94%/yr vs 3.18%/yr for FUL. Their 0.29 correlation means their historical movements had little consistent relationship.
Performance
ABBV vs. FUL - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ABBV achieves a 12.42% return, which is significantly higher than FUL's -5.87% return. Over the past 10 years, ABBV has outperformed FUL with an annualized return of 18.94%, while FUL has yielded a comparatively lower 3.18% annualized return.
ABBV
- 1D
- -2.51%
- 1M
- 0.66%
- 6M
- 14.27%
- YTD
- 12.42%
- 1Y
- 36.88%
- 3Y*
- 23.28%
- 5Y*
- 20.99%
- 10Y*
- 18.94%
- ALL TIME*
- 20.35%
FUL
- 1D
- -0.14%
- 1M
- -3.03%
- 6M
- -6.87%
- YTD
- -5.87%
- 1Y
- -0.01%
- 3Y*
- -7.92%
- 5Y*
- -1.81%
- 10Y*
- 3.18%
- ALL TIME*
- 9.26%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
ABBV AbbVie Inc. | $1.40B | $1.53B | $1.60B |
| $35.21M | $42.96M | $45.53M |
ABBV vs. FUL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 12.42% | 33.08% | 18.86% | -0.23% | 24.01% | 32.43% | 27.72% | 1.47% | -0.96% | 60.07% |
FUL H.B. Fuller Company | -5.87% | -10.46% | -16.19% | 14.97% | -10.59% | 57.84% | 2.15% | 22.42% | -19.84% | 12.79% |
Correlation
The correlation between ABBV and FUL is 0.11, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.11 |
Correlation (3Y) Balances recent behavior with more history. | 0.17 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.20 |
Correlation (10Y) Provides a long-term view across more market conditions. | 0.26 |
Correlation (All Time) Calculated using the full available price history since Jan 2, 2013 | 0.29 |
The correlation between ABBV and FUL shifts across timeframes, from 0.11 (1 year) to 0.29 (all time), reflecting how their relationship changes across market environments.
Fundamentals
ABBV:
$443.24B
FUL:
$2.97B
ABBV:
$2.05
FUL:
$3.36
ABBV:
122.29
FUL:
16.47
ABBV:
7.08
FUL:
0.87
ABBV:
16.19
FUL:
1.46
ABBV:
$62.82B
FUL:
$3.51B
ABBV:
$46.15B
FUL:
$1.14B
ABBV:
$17.96B
FUL:
$511.88M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ABBV vs. FUL — Risk / Return Rank
ABBV
FUL
ABBV vs. FUL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for AbbVie Inc. (ABBV) and H.B. Fuller Company (FUL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ABBV | FUL | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.42 | ||
| Sortino ratioReturn per unit of downside risk | +1.87 | ||
| Omega ratioGain probability vs. loss probability | 1.26 | 1.03 | +0.23 |
| Calmar ratioReturn relative to maximum drawdown | 2.14 | -0.00 | +2.14 |
| Martin ratioReturn relative to average drawdown | 4.73 | -0.00 | +4.74 |
Loading charts...
Drawdowns
ABBV vs. FUL - Drawdown Comparison
The maximum ABBV drawdown since its inception was -45.09%, smaller than the maximum FUL drawdown of -68.25%. Use the drawdown chart below to compare losses from any high point for ABBV and FUL.
Loading charts...
Drawdown Indicators
| ABBV | FUL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -45.09% | -68.25% | +23.16% |
Max Drawdown (1Y)Largest decline over 1 year | -17.32% | -26.97% | +9.65% |
Max Drawdown (3Y)Largest decline over 3 years | -20.74% | -43.45% | +22.71% |
Max Drawdown (5Y)Largest decline over 5 years | -21.92% | -43.45% | +21.53% |
Max Drawdown (10Y)Largest decline over 10 years | -45.09% | -56.29% | +11.20% |
Current DrawdownCurrent decline from peak | -4.69% | -33.83% | +29.14% |
Average DrawdownAverage peak-to-trough decline | -10.64% | -18.80% | +8.16% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.81% | 9.52% | -1.71% |
Volatility
ABBV vs. FUL - Volatility Comparison
AbbVie Inc. (ABBV) and H.B. Fuller Company (FUL) have volatilities of 8.35% and 8.05%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ABBV | FUL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.35% | 8.05% | +0.30% |
Volatility (6M)Calculated over the trailing 6-month period | 19.56% | 27.24% | -7.68% |
Volatility (1Y)Calculated over the trailing 1-year period | 26.14% | 33.78% | -7.64% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.46% | 29.76% | -6.30% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.92% | 31.21% | -5.29% |
Dividends
ABBV vs. FUL - Dividend Comparison
ABBV's dividend yield for the trailing twelve months is around 2.72%, more than FUL's 1.74% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 2.72% | 2.87% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% |
FUL H.B. Fuller Company | 1.74% | 1.56% | 1.29% | 0.99% | 1.03% | 0.82% | 1.25% | 1.23% | 1.44% | 1.10% | 1.14% | 1.40% |
Financials
ABBV vs. FUL - Financials Comparison
This section allows you to compare key financial metrics between AbbVie Inc. and H.B. Fuller Company. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ABBV vs. FUL - Profitability Comparison
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, AbbVie Inc. reported a gross profit of 12.53B and revenue of 15.00B. Therefore, the gross margin over that period was 83.5%.
FUL - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, H.B. Fuller Company reported a gross profit of 322.24M and revenue of 950.27M. Therefore, the gross margin over that period was 33.9%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, AbbVie Inc. reported an operating income of 4.73B and revenue of 15.00B, resulting in an operating margin of 31.6%.
FUL - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, H.B. Fuller Company reported an operating income of 122.83M and revenue of 950.27M, resulting in an operating margin of 12.9%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, AbbVie Inc. reported a net income of 699.00M and revenue of 15.00B, resulting in a net margin of 4.7%.
FUL - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, H.B. Fuller Company reported a net income of 67.81M and revenue of 950.27M, resulting in a net margin of 7.1%.
Frequently Asked Questions
ABBV and FUL have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ABBV has higher volatility (8.35%) compared to FUL (8.05%). In terms of maximum drawdown, ABBV dropped -45.09% vs FUL's -68.25%.
ABBV currently has the higher Sharpe Ratio (1.42 vs -0.00), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ABBV and FUL
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer